基本信息
浏览量:58
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Manfred Windisch founded JSW Lifesciences GmbH, an independent international contract research organization located in Grambach, Austria in the year 1999. JSW specializes on research about neurodegenerative disorders and in his current capacity Dr. Windisch focuses on pharmacological studies of novel compounds for treatment Alzheimer’s, Parkinson’s disease and stroke, from molecular screening up to in vivo model systems, from early screening to phase 3 of clinical studies. In the year 2012 his company was merged with the international CRO QPS, where he continues his work in the function as head of global neuroscience, to further profile the company’s expertise in that field.
After graduation from the University of Graz in 1985 he spent several years heading a neurobiology group at the University with research in the field of brain metabolism and animal model development after which he was involved for many years in University and industrial research programs in Europe, North America and Asia. He established a global network of research collaborations and stimulated intensive scientific information exchange. Besides his involvement in basic research on neurotrophic and neuroprotective factors, he spearheaded several international clinical studies in Alzheimer's disease. He is a highly active member of the scientific community and has authored about 100 original research articles in peer-reviewed journals. He is organizing conferences in the field of drug development for treatment of neurodegenerative diseases and is one of the executive organizers of the ADPD conference. As a member of several scientific advisory boards he is helping to coordinate preclinical and clinical research activities in that field on an international level.
He is also active in creating improved models of neurodegenerative diseases, which should allow early drug testing with a higher predictive value.
In August 2013 he founded a new company “NeuroScios – Neuroscience Optimized Solutions” and took over the position as a CEO there. This company is highly specialized in consulting for complete drug development programs in neurological indications and it provides premier expertise in clinical trials in dementia (AD; MCI and others) as well as cerebro-vascular disorders (stroke). The basis for the quality of his consulting are 35 years of experience in AD-research and about 15 years of intense work with disease models, practically being exposed to all types of treatment approaches for AD.
研究兴趣
论文共 183 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NATURE MEDICINEno. 5 (2024): 1761-1770
Alzheimer's & Dementiano. S10 (2022)
Alzheimer's & Dementiano. 7S_Part_17 (2016)
Alzheimer's & Dementiano. 7S_Part_21 (2016)
加载更多
作者统计
#Papers: 184
#Citation: 4599
H-Index: 36
G-Index: 64
Sociability: 7
Diversity: 3
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn